Get the Stockscreener App
16.00
0.63%
0.10
After Hours:
16.32
0.32
+2.00%
Polyrizon Ltd stock is traded at $16.00, with a volume of 51,685.
It is up +0.63% in the last 24 hours and up +26.88% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$15.90
Open:
$15.89
24h Volume:
51,685
Relative Volume:
1.00
Market Cap:
$29.95M
Revenue:
-
Net Income/Loss:
$-3.34M
P/E Ratio:
-5.927
EPS:
-2.6995
Net Cash Flow:
$-10.54M
1W Performance:
+2.83%
1M Performance:
+26.88%
6M Performance:
+161.44%
1Y Performance:
-95.79%
1-Day Range:
$15.66
$17.50
1-Week Range:
$14.00
$17.50
52-Week Range:
$2.88
$2,235.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
16.00 | 30.89M | 0 | -3.34M | -10.54M | -2.6995 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Polyrizon Ltd Stock (PLRZ) Latest News
MMCAP, MM Asset Mgmt (PLRZ) joint filing reports 7.3% ownership - Stock Titan
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon Files European Patent Application for Trap & Target Intranasal Drug Delivery Platform - TipRanks
Polyrizon files European patent for intranasal drug delivery tech By Investing.com - Investing.com Canada
Polyrizon files European patent for intranasal drug delivery tech - Investing.com
Polyrizon Ltd. Files Divisional Patent Application for Advanced Trap & Target Intranasal Drug Delivery Technology - Quiver Quantitative
Polyrizon seeks Europe patent for system designed to keep nasal drugs in place - Stock Titan
Polyrizon signs MOU to acquire up to 20% stake in eVTOL firm Colugo - MSN
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Polyrizon shares gain on plan to buy majority stake in private aviation company - MSN
Polyrizon Ltd. (PLRZ) registers 499,999 shares for resale under Form F-1 - Stock Titan
PLRZ Technical Analysis | Trend, Signals & Chart Patterns | POLYRIZON LTD (NASDAQ:PLRZ) - ChartMill
Is Polyrizon (PLRZ) stock losing momentum (In Focus) 2026-04-18Insider Buying - Cổng thông tin điện tử tỉnh Tây Ninh
Polyrizon (PLRZ) Stock: The Bull Case (On the Radar) 2026-04-15High Beta Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Energy Moves: Can Polyrizon Ltd deliver consistent EPS growth2026 Setups & Reliable Intraday Trade Alerts - baoquankhu1.vn
Geopolitics Watch: Will AOMR announce a stock split2026 Stock Rankings & Fast Momentum Entry Tips - baoquankhu1.vn
PLRZ.O Technical Analysis & Stock Price Forecast - Intellectia AI
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements - The Manila Times
Polyrizon Raises $3.5 Million via Registered Direct Offering and Private Placement - TipRanks
Polyrizon Ltd. Completes $3.5 Million Registered Direct Offering and Private Placement - Moomoo
Polyrizon raises $3.5M in stock sale for working capital - Stock Titan
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Polyrizon Ltd. (PLRZ) files $2.5M offering: 87,777 shares + 190,000 pre-funded warrants - Stock Titan
Polyrizon raises $3.5M through registered direct offering By Investing.com - Investing.com Australia
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement - Bitget
Analysis Recap: Can Polyrizon Ltd deliver consistent EPS growth2026 Spike Watch & Daily Entry Point Trade Alerts - baoquankhu1.vn
Polyrizon raises $3.5M through registered direct offering - Investing.com
Polyrizon LtdEnters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants - TradingView — Track All Markets
Technical Analysis: Can Polyrizon Ltd weather a recession2026 Support & Resistance & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Aug Volume: Can Polyrizon Ltd weather a recessionCEO Change & Intraday High Probability Setup Alerts - baoquankhu1.vn
PLRZ Should I Buy - Intellectia AI
PLRZ.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PLRZ News & Events - Intellectia AI
PLRZ SEC FilingsPolyrizon Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Sell: CEO Tomer Izraeli Sells 500 Shares of Polyrizon Lt - GuruFocus
Polyrizon (PLRZ) CEO sells 500 shares in open-market trade - Stock Titan
Carmel Liron of Polyrizon (PLRZ) sells 942 shares, holds 3,127 - Stock Titan
Polyrizon (PLRZ) director sells 3,292 shares, retains 19,850 total - Stock Titan
Patterns Watch: Can Polyrizon Ltd beat the S P 500Entry Point & Expert Curated Trade Ideas - baoquankhu1.vn
Levels Update: Will Polyrizon Ltd outperform its industry peers2026 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Top Polyrizon Insiders Quietly Cash Out in Notable Stock Moves - TipRanks
Insiders Make Big Moves at Polyrizon as Directors Cash Out Company Stock - TipRanks
Director at Polyrizon (PLRZ) sells 100 shares, retains 4,069 - Stock Titan
Polyrizon Ltd Stock (PLRZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Polyrizon Ltd Stock (PLRZ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Carmel Liron | Director |
Mar 31 '26 |
Sale |
12.36 |
942 |
11,643 |
3,127 |
| Adler Oz | Director |
Mar 31 '26 |
Sale |
12.05 |
3,292 |
39,669 |
19,850 |
| Carmel Liron | Director |
Mar 30 '26 |
Sale |
11.00 |
100 |
1,100 |
4,069 |
| Izraeli Tomer | Chief Executive Officer |
Mar 30 '26 |
Sale |
10.90 |
3,900 |
42,510 |
32,012 |
| Turgeman Tidhar | Chief Technology Officer |
Mar 30 '26 |
Sale |
10.90 |
2,917 |
31,795 |
17,518 |
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):